Cardiac Arrhythmia
120
16
23
61
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
16 trials with published results (13%)
Research Maturity
61 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.5%
3 terminated out of 120 trials
95.3%
+8.8% vs benchmark
3%
3 trials in Phase 3/4
26%
16 of 61 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 61 completed trials
Clinical Trials (120)
StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias
Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest
Remote Patient Management of CIEDs
Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias
Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)
CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm
Modified Left Atrial Maze Procedure for Concomitant AF Ablation
Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II
Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA
Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization
Post-market Clinical Follow-up Data Collection From Procedures With BIOTRONIK EP Products
Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)
N-Acetylcysteine Protection Against Radiation Induced Cellular Damage
Quality of Cardiopulmonary Resuscitation Pre- and Intra Hospital
Pulsed ElectRic FiEld Versus Cryoballoon for PAF
AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
Investigation of Therapeutic Ablation Versus Cardioversion for AF
Colchicine After Electrocardioversion for Atrial Fibrillation